Targeted therapy of hormone receptor-positive breast cancer harboring PIK3CA and AKT1 genetic aberrations

被引：0
|
作者：
Shariati, Maryam
Evans, Kurt W.
Scott, Stephen M.
Chen, Huiqin
Meric-Bernstam, Funda
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
135
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Mutational Analysis of AKT1 and PIK3CA in Intraductal Papillomas of the Breast with Special Reference to Cellular Components
    Mishima, Chieko
    Kagara, Naofumi
    Ikeda, Jun-ichiro
    Morii, Eiichi
    Miyake, Tomohiro
    Tanei, Tomonori
    Naoi, Yasuto
    Shimoda, Masafumi
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (05): : 1106 - 1112
  • [32] Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants
    Wen Tian
    Yingzhao Huang
    Liying Sun
    Yang Guo
    Sen Zhao
    Mao Lin
    Xiying Dong
    Wenyao Zhong
    Yuehan Yin
    Zefu Chen
    Nan Zhang
    Yuanqiang Zhang
    Lianlei Wang
    Jiachen Lin
    Zihui Yan
    Xinzhuang Yang
    Junhui Zhao
    Guixing Qiu
    Jianguo Zhang
    Zhihong Wu
    Nan Wu
    Orphanet Journal of Rare Diseases, 15
  • [33] PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
    Crowder, Robert J.
    Phommaly, Chanpheng
    Tao, Yu
    Hoog, Jeremy
    Luo, Jingqin
    Perou, Charles M.
    Parker, Joel S.
    Miller, Melinda A.
    Huntsman, David G.
    Lin, Li
    Snider, Jacqueline
    Davies, Sherri R.
    Olson, John A., Jr.
    Watson, Mark A.
    Saporita, Anthony
    Weber, Jason D.
    Ellis, Matthew J.
    CANCER RESEARCH, 2009, 69 (09) : 3955 - 3962
  • [34] Germline mutations in PIK3CA and AKT1 in Cowden syndrome and related diseases
    Dereure, O.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2013, 140 (11): : 739 - 740
  • [35] Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
    Yi, Zongbi
    Ma, Fei
    Liu, Binliang
    Guan, Xiuwen
    Li, Lixi
    Li, Chunxiao
    Qian, Haili
    Xu, Binghe
    BMC CANCER, 2019, 19 (1)
  • [36] Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
    Zongbi Yi
    Fei Ma
    Binliang Liu
    Xiuwen Guan
    Lixi Li
    Chunxiao Li
    Haili Qian
    Binghe Xu
    BMC Cancer, 19
  • [37] Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
    Miguel Cejalvo, Juan
    Alejandro Perez-Fidalgo, J.
    Ribas, Gloria
    Burgues, Octavio
    Mongort, Cristina
    Alonso, Elisa
    Ibarrola-Villava, Maider
    Bermejo, Begona
    Teresa Martinez, Maria
    Cervantes, Andres
    Lluch, Ana
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (01) : 69 - 77
  • [38] Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
    Juan Miguel Cejalvo
    J. Alejandro Pérez-Fidalgo
    Gloria Ribas
    Octavio Burgués
    Cristina Mongort
    Elisa Alonso
    Maider Ibarrola-Villava
    Begoña Bermejo
    María Teresa Martínez
    Andrés Cervantes
    Ana Lluch
    Breast Cancer Research and Treatment, 2016, 160 : 69 - 77
  • [39] AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients' biopsies and matched urine
    El Ahanidi, Hajar
    El Azzouzi, Meryem
    Arrouchi, Housna
    Alaoui, Chaimae Hafidi
    Tetou, Mohammed
    Bensaid, Mounia
    Oukabli, Mohamed
    Ameur, Ahmed
    Al Bouzidi, Abderrahmane
    El Mzibri, Mohammed
    Attaleb, Mohammed
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [40] Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial
    Nicholas Turner
    Rebecca A. Dent
    Joyce O’Shaughnessy
    Sung-Bae Kim
    Steven J. Isakoff
    Carlos Barrios
    Shigehira Saji
    Igor Bondarenko
    Zbigniew Nowecki
    Qinshu Lian
    Sarah-Jayne Reilly
    Heather Hinton
    Matthew J. Wongchenko
    Bruno Kovic
    Aruna Mani
    Mafalda Oliveira
    Breast Cancer Research and Treatment, 2022, 191 : 565 - 576
12345